News

People who can't have a vaccine because they are immunocompromised may get access to a Covid-19 treatment.

Scottish pharmacies have been forced to close by the country’s Test and Protect programme because staff were not wearing appropriate PPE.

The CAC sides with the PDA Union on the proposed bargaining unit, rejecting Lloyds' claim that all store workers should be included. 

Jo’s Cervical Cancer Trust has launched two new support services in response to increasing demand during the Covid-19 pandemic.

The DHSC has today announded the second wave of price concessions for November.

NHS Long Term Plan is to introduce digital prescribing across the entire NHS by 2024.

LloydsPharmacy parent company McKesson UK is “insisting” on a 25 per cent discount from its health centre landlords.

The government has extended the visas of thousands more overseas health workers including pharmacists.

Ninety-five per cent of Kent pharmacies experienced problems with staffing levels during the first wave of the coronavirus pandemic.

DHSC will advise which wholesalers have been allocated stock via the NHSBSA website.

The majority of LPCs think their relationship with PSNC has improved over the past year despite the turmoil of Covid-19, according to poll.

The number of community pharmacies in England dropped to its lowest level in five years by the end of March 2020.

The extensive and under-recognised impact eczema can have on all aspects of people’s lives are revealed in a new report.

The autonomous vehicle is the first such vehicle to travel on roads in the UK.

A drug used to treat sleep disorders carries a risk of birth defects when taken in pregnancy.  

A split pre-reg scheme has increased the number of trainees to surgeries this year.

The ‘Help Us Help You – Abdominal Symptoms of Cancer’ campaign launched on 9 November 2020.

Young people with eating disorders such as bulimia and anorexia are to gain access to specialist support across England.

Government say Pfizer/BioNTech and Oxford vaccines could be available before year end

New company will rival Teva in global generics market.